GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype

Enrolling by invitation

Conditions studied: Alzheimer Disease

In brief

The purpose of the Alzheimer's Prevention Registry GeneMatch program is to identify a large group of people interested in participating in research studies or clinical trials based in part on their genetic background. This genetic information will be used to match interested individuals to studies, providing a recruitment resource to the Alzheimer's scientific community. Interested individuals should visit www.endALZnow.org/GeneMatch to join the GeneMatch program.

Key facts

Study ID

NCT02564692

Run by

Banner Health

People needed

500000

Starts

2015-11-01

Expected to finish

2030-12-01

Last updated by the study team

2025-12-09

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 50-90, inclusive
• Provide basic demographic, medical history, and contact information
• Consent to APOE genotyping without receiving results
• Live in the United States

You may not qualify if…

• Unable to comply with this project's protocol requirements
• Self-reported diagnosis of dementia or any other objective cognitive impairment syndrome

Where it is running

• Banner Alzheimer's Institute — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.